Cargando…
Adapted systemic inflammation score as a novel prognostic marker for esophageal squamous cell carcinoma patients
BACKGROUND: The adapted systemic inflammation score (aSIS), calculated from serum albumin and the lymphocyte‐to‐monocyte ratio, has been reported to be a novel prognostic marker for some types of cancers. However, the prognostic impact of aSIS in patients with esophageal squamous cell carcinoma (ESC...
Autores principales: | Nomoto, Daichi, Baba, Yoshifumi, Akiyama, Takahiko, Okadome, Kazuo, Iwatsuki, Masaaki, Iwagami, Shiro, Miyamoto, Yuji, Yoshida, Naoya, Watanabe, Masayuki, Baba, Hideo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452479/ https://www.ncbi.nlm.nih.gov/pubmed/34585051 http://dx.doi.org/10.1002/ags3.12464 |
Ejemplares similares
-
Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma
por: Baba, Yoshifumi, et al.
Publicado: (2020) -
PD‐L1 and PD‐L2 expression status in relation to chemotherapy in primary and metastatic esophageal squamous cell carcinoma
por: Okadome, Kazuo, et al.
Publicado: (2021) -
Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancer
por: Kalikawe, Rebecca, et al.
Publicado: (2019) -
Port site recurrence of esophageal adenocarcinoma after minimally invasive esophagectomy: a case report
por: Horino, Taichi, et al.
Publicado: (2020) -
Indoleamine 2, 3‐dioxygenase 1 promoter hypomethylation is associated with poor prognosis in patients with esophageal cancer
por: Kiyozumi, Yuki, et al.
Publicado: (2019)